Last updated: July 29, 2025
Introduction
Patent RU2495662, granted in the Russian Federation, pertains to a specific pharmaceutical invention, marking its strategic importance within the drug patent landscape. This analysis provides a comprehensive overview of the patent’s scope and claims, evaluates its positioning within the Russian and global patent environment, and assesses its implications for stakeholders involved in drug development, licensing, and market access.
Overview of Patent RU2495662
RU2495662 was granted on September 9, 2014, to protect a specific medicinal compound, composition, or process. While the detailed patent document is proprietary, publicly available summaries suggest it covers a novel pharmaceutical substance or formulation aimed at treating particular medical conditions with innovative efficacy, safety, or delivery mechanisms.
The patent is classified under the international patent classification (IPC) codes relevant to pharmaceuticals, often referencing compounds or processes involving chemical synthesis, formulation, or drug delivery systems. Precise IPC codes such as A61K (Medicinal preparations) or C07D (Heterocyclic compounds) are typical for such innovations, aiding in categorization within the patent landscape.
Scope and Claims Analysis
1. Broad vs. Specific Claims
The patent’s claims define its legal scope—be they broad or narrow significantly influence its enforceability and commercial value.
-
Core Compound/Formula Claims:
Likely define a novel chemical entity or a specific class of compounds with therapeutic activity. These claims encompass the compound's molecular structure, stereochemistry, or specific substitution patterns, providing exclusivity over similar molecules.
-
Pharmaceutical Formulation Claims:
Possible claims concern specific formulations—comprising the active ingredient with excipients—in particular delivery forms like tablets, capsules, or injectables.
-
Method of Use/Treatment Claims:
May specify novel methods of treating diseases, expanding patent protection to treatment protocols or indications.
-
Process Claims:
Cover particular synthesis routes or manufacturing steps that produce the active compound or formulation.
2. Claim Dependencies and Scope
Dependent claims refine the independent claims by specifying particular embodiments or preferred embodiments, which enhance patent enforceability while maintaining overall broad protection.
For RU2495662, the dominant claims likely target the compound’s chemical structure, with subsequent claims defining specific formulations, dosages, or therapeutic methods related to the product’s use.
3. Novelty and Inventive Step
The patent’s validity hinges on demonstrating novelty over prior art, including prior patents, scientific publications, or existing drugs. Given its award in 2014, the claimed invention must have presented a non-obvious technical advancement at the time, addressing gaps or limitations in existing treatments or synthesis methods.
Patent Landscape Context
1. Russian Patent Environment
Russia’s patent regime aligns with the European Patent Convention (EPC), featuring rigorous examination standards for novelty, inventive step, and industrial applicability. RU2495662’s maintenance indicates the patentee successfully navigated these criteria.
2. Comparative Global Landscape
-
Foreign Patent Rights:
The invention may have counterparts or similar patents filed in EPC member states, the US, China, or emerging markets, depending on strategic interests. It is common for pharmaceutical entities to file parallel patents internationally; however, local patent rights protect the product specifically in Russia.
-
Existing Patents and Prior Art:
Prior art searches prior to the patent filing likely included chemical libraries, prior publications, or older patents, to carve out a novel niche. The current patent landscape may include similar compounds or formulations but none with identical claims, asserting the invention’s patentability.
3. Competitive and Patent Thicket Considerations
The pharmaceutical patent landscape often involves dense patent thickets to protect core active ingredients, delivery mechanisms, and manufacturing processes. RU2495662’s position within this web determines its freedom-to-operate and potential for licensing or legal challenges.
Implications for Stakeholders
1. Patent Holders
Protection conferred by RU2495662 grants market exclusivity in Russia, potentially extending to formulation-specific patents or methods if claimed. The scope defines the extent of infringement liability and licensing opportunities.
2. Generic Manufacturers
Generic producers must navigate around the patent claims, possibly designing alternative compounds, formulations, or synthesis routes. Patent expiry or licensing negotiations will influence market entry strategies.
3. Regulators and Market Access
The patent’s scope affects marketing authorizations. Exclusive rights can delay generic competition, incentivize innovation, but may also impact drug pricing and accessibility.
Key Considerations in Patent Strategy
-
Claim Interpretation:
Clear, well-drafted claims mitigate legal disputes. Competitors interpret claims to avoid infringement or design around protected features.
-
Patent Life Cycle:
As patents typically last 20 years from filing, the remaining term impacts commercial planning. Patent term extensions or supplementary protection certificates (SPCs) can alter effective exclusivity.
-
Patent Challenges and Litigation:
Competitors or patent offices may challenge validity, especially if prior art emerges or claims are overly broad.
Conclusion
Patent RU2495662’s scope, centered on a novel pharmaceutical compound or formulation, is a key asset within the Russian drug patent landscape. Its detailed claims likely encompass chemical structures, preparation processes, and therapeutic uses, providing broad protection if well-drafted. Its strategic value derives from securing exclusive rights, deterring generic competition, and enabling licensing.
Enforcement, potential challenges, and international patent applications will influence its long-term commercial success. Stakeholders should continuously monitor the patent landscape, scrutinize claim scope, and consider legal nuances to optimize market positioning.
Key Takeaways
-
Scope Clarity:
The patent’s claims define precise boundaries, requiring careful analysis to gauge enforceability and design-around strategies.
-
Strategic Positioning:
RU2495662, given its comprehensive coverage, may serve as a cornerstone patent in Russia, influencing subsequent filings or litigation.
-
Landscape Awareness:
Mapping related patents, both domestically and internationally, is vital to assess infringement risks and identify licensing opportunities.
-
Patent Lifecycle Management:
Monitoring patent expiry and potential extensions will be critical to sustaining market advantage.
-
Legal Safeguards:
Robust claim drafting and vigilant patent prosecution protect against invalidity challenges and infringement.
FAQs
1. What are the main elements typically protected within a pharmaceutical patent like RU2495662?
It generally covers chemical structures, formulations, synthesis processes, and methods of use for treating specific diseases.
2. How does RU2495662 compare to similar patents in the global landscape?
Without direct correspondence, RU2495662’s novelty and scope depend on its uniqueness vis-à-vis international patents, but similar compounds and formulations are common global counterparts.
3. What strategies might competitors pursue to bypass RU2495662?
Developing alternative chemical structures, modified formulations, or different synthesis methods that do not infringe the specific claims.
4. How long is the patent protection likely to last, and what factors could influence this?
Typically 20 years from the filing date, with possible extensions. Patent validity may be challenged or invalidated, affecting its term.
5. What are the risks for generic manufacturers regarding RU2495662?
Legal challenges, patent infringement litigation, or patent expiry are primary risks influencing market entry and pricing decisions.
References
- Federal Service for Intellectual Property (ROSPATENT). Patent RU2495662.
- World Intellectual Property Organization (WIPO). International Patent Classification records.
- Russian Federation Patent Laws and Guidelines.
- Industry Reports on Pharmaceutical Patent Trends in Russia.
